Liquidation: AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS)

Form Type: 497

Filing Date: 2025-04-01

Corporate Action: Liquidation

Type: Update

Accession Number: 000110465925029999

Filing Summary: The document is an EDGAR HTML supplement dated March 31, 2025, amending the Summary and Statutory Prospectuses for Invesco® V.I. Nasdaq 100 Buffer Fund and Invesco® V.I. S&P 500 Buffer Fund. It announces the termination, liquidation, and dissolution of the Nasdaq 100 Buffer Fund on or about April 30, 2025, following the end of its current Outcome Period on March 31, 2025. The Fund's portfolio managers plan to increase cash holdings to meet expenses and redemption requests as the Fund prepares for liquidation. The document also outlines the caps for a new Outcome Period starting April 1, 2025, for both funds, detailing their respective caps before and after fees and expenses, and specifies the amendment of all relevant references in the Prospectuses to align with the new Outcome Period.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-04-01

Corporate Action: Liquidation

Type: Update

Accession Number: 000110465925030000

Filing Summary: This document is a supplement to the current summary and statutory prospectuses for the Invesco® V.I. Nasdaq 100 Buffer Fund - March. It amends the existing prospectuses, detailing that the Fund will transition into a new Outcome Period starting April 1, 2025, and terminate on or about April 30, 2025, whereupon it will undergo liquidation. The Board of Trustees has approved this decision. Preparation for Fund closure includes increasing cash reserves to manage expenses and redemption requests, which may divert from the usual investment strategy. The Fund's annual outcomes are designed to align returns with the Nasdaq 100 Index up to a cap while providing a buffer against losses, but the ability to achieve these outcomes may be compromised before liquidation.

Document Link: View Document

Form Type: 497

Filing Date: 2025-03-24

Corporate Action: Liquidation

Type: Update

Accession Number: 000119312525061200

Filing Summary: This document serves as a supplement dated March 24, 2025, amendment to the Summary and Statutory Prospectuses for the Invesco® V.I. Nasdaq 100 Buffer Fund and Invesco® V.I. S&P 500 Buffer Fund. It outlines the termination, liquidation, and dissolution of the Nasdaq 100 Buffer Fund effective on or about April 30, 2025. This liquidation process entails that the fund's portfolio managers will increase cash holdings to meet expenses and redemption requests, potentially altering its investment strategies. Additionally, the document provides estimates for the new Cap ranges for both funds starting April 1, 2025, before and after taking into account fees and expenses. The document warns that achieving the Defined Outcomes prior to liquidation is not guaranteed due to this strategic change.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-03-24

Corporate Action: Liquidation

Type: Update

Accession Number: 000119312525061203

Filing Summary: This document serves as a supplement dated March 24, 2025, to the Summary and Statutory Prospectuses for the Invesco® V.I. Nasdaq 100 Buffer Fund. It outlines that the Fund aims to provide returns matching those of the Nasdaq 100 Index® up to an upside cap while offering protection against the first 10% of losses from the Index. The current Outcome Period concludes on March 31, 2025, after which a new Outcome Period will begin on April 1, 2025. The document reveals that the Board of Trustees has approved the termination and liquidation of the Fund, aiming for completion on or about April 30, 2025. To facilitate this process, the Fund's portfolio managers intend to increase cash holdings, potentially deviating from the investment strategies. This might impact the likelihood of achieving the Defined Outcomes before the Liquidation Date. The expected Cap for the new Outcome Period is estimated to be within the ranges provided, pending market conditions and before Fund fees and expenses. The Cap determination will occur at the end of the trading day on March 31, 2025, before the new Outcome Period starts.

Document Link: View Document

Form Type: 497

Filing Date: 2025-01-02

Corporate Action: Liquidation

Type: Update

Accession Number: 000110465924132928

Filing Summary: The document is a supplement to the Summary and Statutory Prospectuses for Invesco® V.I. Nasdaq 100 Buffer Fund and Invesco® V.I. S&P 500 Buffer Fund. It states that the Funds will undergo termination, liquidation, and dissolution on or about April 30, 2025. The portfolio managers will increase cash holdings to handle expenses and meet redemption requests, which may deviate from the existing investment strategies and objectives. The document outlines new Outcome Periods starting January 1, 2025, with corresponding caps before and after expenses. Nasdaq 100 Buffer Fund will have a cap of 16.15% before fees and 15.34% after, while the S&P 500 Buffer Fund will have a cap of 12.92% before fees and 12.13% after. The references to Outcome Periods and caps in the Prospectuses have been revised accordingly.

Document Link: View Document

Form Type: 497K

Filing Date: 2025-01-02

Corporate Action: Liquidation

Type: Update

Accession Number: 000110465924132929

Filing Summary: This document acts as a supplement amending the Summary and Statutory Prospectuses for the Invesco® V.I. Nasdaq 100 Buffer Fund. It informs that the Fund, which seeks to provide returns matching the Nasdaq 100 Index up to a cap with a 10% loss buffer, will enter a new Outcome Period starting January 1, 2025. The Board of Trustees has approved the termination, liquidation, and dissolution of the Fund, anticipated around April 30, 2025. In preparation for the liquidation, the Fund's asset management strategy will shift towards cash and similar instruments to cover expenses and redemption requests, indicating a deviation from its initial investment strategies. The new cap for the upcoming Outcome Period has been specified before and after accounting for Fund fees and expenses, ensuring shareholders are informed of changes to their investment outcomes prior to the liquidation date.

Document Link: View Document

Form Type: 497

Filing Date: 2024-12-23

Corporate Action: Liquidation

Type: Update

Accession Number: 000119312524284051

Filing Summary: This supplement amends the Summary and Statutory Prospectuses for the Invesco® V.I. Nasdaq 100 Buffer Fund and the Invesco® V.I. S&P 500 Buffer Fund, indicating the termination, liquidation, and dissolution of the Funds on or about April 30, 2025. The Funds will prepare for the closing by increasing their cash holdings to meet expenses and redemption requests. The outcome period will reset on January 1, 2025, with current cap estimates provided for both Funds.

Document Link: View Document

Form Type: 497K

Filing Date: 2024-12-23

Corporate Action: Liquidation

Type: Update

Accession Number: 000119312524284054

Filing Summary: This document is a supplement to the current prospectuses for the Invesco® V.I. Nasdaq 100 Buffer Fund, indicating that the Fund will be liquidated on or about April 30, 2025. To prepare for this, the Fund will increase its cash reserves, potentially altering its investment strategies. Key details include the reset of the Fund's Cap and the expected Cap range for the new Outcome Period, beginning January 1, 2025.

Document Link: View Document

Form Type: 497

Filing Date: 2024-12-16

Corporate Action: Liquidation

Type: Update

Accession Number: 000119312524279539

Filing Summary: On December 11, 2024, the Board of Trustees of AIM Variable Insurance Funds approved a Plan of Liquidation and Dissolution for the Invesco V.I. Nasdaq 100 Buffer Funds. New investments and additional purchases will cease after January 17, 2025; however, existing shareholders can continue to invest until approximately April 16, 2025. Liquidation is expected to occur around April 30, 2025. Shareholders may redeem their shares at any time before this date, and cash and cash equivalents will increasingly be held, potentially leading to lower returns. Liquidating distributions to shareholders will be made equal to their proportionate interest in the net assets, and the liquidation is not expected to be a taxable event for variable contract owners. Shareholders cannot directly redeem shares; they must go through their insurance company.

Document Link: View Document

Form Type: 497K

Filing Date: 2024-12-16

Corporate Action: Liquidation

Type: Update

Accession Number: 000119312524279546

Filing Summary: The Board of Trustees for AIM Variable Insurance Funds has approved a Plan of Liquidation and Dissolution for the Invesco® V.I. Nasdaq 100 Buffer Funds. The funds will cease to accept new investments after January 17, 2025, and existing shareholders will be allowed to invest until approximately April 16, 2025. The liquidation process is anticipated to conclude by April 30, 2025, although earlier liquidation may occur if there are no shares outstanding. Shareholders can redeem their shares before the Liquidation Date, but they must do so through their insurance company. Dividends may be declared to distribute remaining investment company taxable income and net capital gain. Liquidation is not expected to be a taxable event for variable life and/or annuity contract owners. Shareholders should consult their tax advisors for specific guidance.

Document Link: View Document

Form Type: 497K

Filing Date: 2024-12-16

Corporate Action: Liquidation

Type: Update

Accession Number: 000119312524279547

Filing Summary: The Board of Trustees of AIM Variable Insurance Funds approved a Plan of Liquidation and Dissolution, leading to the termination of the Invesco V.I. Nasdaq 100 Buffer Funds. New investments will be halted after January 17, 2025, with existing shareholders allowed to invest until approximately April 16, 2025. Liquidation is expected on or around April 30, 2025, unless earlier events occur that result in no outstanding shares. Shareholders may redeem their shares prior to the Liquidation Date. Each Fund will likely hold more cash, impacting its investment strategies and potential performance. Liquidating distributions will be made to shareholders post-liquidation.

Document Link: View Document

Form Type: 497K

Filing Date: 2024-12-16

Corporate Action: Liquidation

Type: New

Accession Number: 000119312524279550

Filing Summary: The Board of Trustees of AIM Variable Insurance Funds approved a Plan of Liquidation and Dissolution for the Invesco® V.I. Nasdaq 100 Buffer Funds. The liquidation process involves closing the funds to new investments after January 17, 2025, while allowing existing shareholders to invest until approximately April 16, 2025. The liquidation is anticipated to occur around April 30, 2025. Shareholders can redeem their shares at any time prior to the Liquidation Date. The funds will transition to holding cash and similar instruments to prepare for expenses and redemption requests, potentially affecting investment performance. A liquidating distribution will be made to shareholders post-liquidation, and it is not expected to trigger tax liabilities for contract owners of variable life and/or annuity contracts, though tax advice is recommended.

Document Link: View Document

Form Type: 497K

Filing Date: 2024-12-16

Corporate Action: Liquidation

Type: Update

Accession Number: 000119312524279551

Filing Summary: AIM Variable Insurance Funds (Invesco Variable Insurance Funds) announced the approval of a Plan of Liquidation and Dissolution for the Invesco® V.I. Nasdaq 100 Buffer Funds. The plan, approved by the Board of Trustees on December 11, 2024, mandates the close of the funds to new investment accounts after January 17, 2025, with existing shareholders allowed to continue investing until approximately April 16, 2025. Liquidation is scheduled for approximately April 30, 2025. Shareholders may redeem their shares until the Liquidation Date, though they cannot exchange shares for other funds. The document also discusses the potential tax implications for contract owners and outlines that the liquidation may not be a taxable event for variable life and/or annuity contract owners. It emphasizes the expected shift to cash holdings for the funds to meet expenses and redemption requests as the liquidation period approaches.

Document Link: View Document